Digoxin tablets.
D001702:Biopharmaceutics; D004077:Digoxin / Q000009:adverse effects / Q000378:metabolism / Q000592:standards* / Q000627:therapeutic use; D004345:Drug Industry; D006801:Humans; D014481:United States; D014486:United States Food and Drug Administration
D004077:Digoxin